Former Chief Executive Officer · Bioventus Inc. (BVS)

Kenneth Reali

A named executive officer of Bioventus in every fiscal year CompBrief holds from FY2020 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$1,319,972

Salary $193,151Stock awards $0Bonus $548,808

FY2022: $4,395,233

2nd of 4 named executive officers at Bioventus by FY2023 total.

4 named officers on file for Bioventus, FY2023

Kenneth Reali’s pay file — $29

  • 4 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Bioventus’s whole pay program stands against its peers

  • Bioventus’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on BVS→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 26, 2024 (DEF 14A).

Free

Get Kenneth Reali’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Kenneth Reali compensation by year

Bioventus Summary Compensation Table · all 4 fiscal years held
In US dollars, as Bioventus reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021FY2022FY2023
Salary$428,135$690,452$737,397$193,151
Bonus$9,282$0$0$548,808
Stock awards$4,111,191$0$1,454,406$0
Option awards$38,631$10,844,129$2,181,133$0
Non-equity incentive$426,634$1,057,517$0$0
Pension and deferred compensation$0$0$0$0
All other$277,719$26,785$22,297$578,013
Total$5,291,592$12,618,883$4,395,233$1,319,972

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Bioventus Inc. DEF 14A filed April 26, 2024, accession 0001628280-24-018431, and prior-year filings.

How this page was built: the Bioventus Inc. filed document, accession 0001628280-24-018431. Every figure is read from that document and cited to the page and table it appears in. Filed April 26, 2024.

$5.3M
$12.6M
$4.4M
$1.3M
FY20
FY21
FY22
FY23
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
RSU114,882$299,842—
Option466,054—$12.66
Option309,225—$13.00
Option1,391,513—$13.00
Option22,500—$15.23

Per the Outstanding Equity Awards at Fiscal Year-End table in Bioventus Inc.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.

Bioventus’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Anthony BihlFormer Interim Chief Executive Officer$1,614,108
Kenneth Reali · this pageFormer Chief Executive Officer$1,319,972
Mark SingletonSenior Vice President & Chief Financial Officer$1,058,233
Anthony D'AdamioSenior Vice President & General Counsel$924,518

Board service

Bioventus board · FY2021

How this board is paid

Company policy: Bioventus pays directors a $55,000 cash retainer and $152,000 in RSUs. As stated in Bioventus's FY2021 proxy.

The full Bioventus compensation record

free company brief

This page is one person within Bioventus's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Bioventus's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Kenneth Reali's compensation dossier · One-time report. No refunds.